Home
About
Overview
Sharing Data
ORCID
Help
History (71)
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy.
Becker, Michael
Out-of-hospital stroke screen accuracy in a state with an emergency medical services protocol for routing patients to acute stroke centers.
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Targeting the tumor microenvironment with interferon-ß bridges innate and adaptive immune responses.
See All 71 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the tumor microenvironment with interferon-ß bridges innate and adaptive immune responses.
Targeting the tumor microenvironment with interferon-ß bridges innate and adaptive immune responses. Cancer Cell. 2014 Jan 13; 25(1):37-48.
View in:
PubMed
subject areas
Adaptive Immunity
Animals
Antibodies
B7-H1 Antigen
Cell Line, Tumor
Cross-Priming
Dendritic Cells
Enzyme-Linked Immunosorbent Assay
ErbB Receptors
Flow Cytometry
Immunity, Innate
Immunotherapy
Interferon-beta
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Transgenic
Neoplasms, Experimental
Tumor Microenvironment
authors with profiles
Ralph Weichselbaum
Thomas Gajewski